Acadia Pharmaceuticals Inc (ACAD): Total Assets
$1.56B
As of 2025-12-31
$1.74B
As of 2026-06-30
+38.6%
3-year compound annual growth
+14.9%
5-year compound annual growth
+21.6%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.56B | +31.7% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $1.19B | +58.6% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $748.96M | +27.4% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $587.81M | -16.0% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $700.12M | -10.5% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $782.62M | -0.1% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $783.18M | +45.0% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $540.20M | +40.5% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $384.51M | -31.5% | 2019-02-27, Balance as of period end |
| 2016-12-31 | $561.15M | +152.9% | 2018-02-27, Balance as of period end |
| 2015-12-31 | $221.90M | -31.8% | 2017-02-28, Balance as of period end |
| 2014-12-31 | $325.46M | +72.1% | 2016-02-29, Balance as of period end |
| 2013-12-31 | $189.12M | +74.2% | 2015-02-26, Balance as of period end |
| 2012-12-31 | $108.59M | +238.1% | 2014-02-27, Balance as of period end |
| 2011-12-31 | $32.11M | -16.4% | 2013-03-12, Balance as of period end |
| 2010-12-31 | $38.39M | n/a | 2012-03-06, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $1.56B | +31.7% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $3.49B | +2.7% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $1.26B | +20.9% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $3.52B | +17.3% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $1.20B | -8.7% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $1.44B | +12.1% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $1.27B | +27.3% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $1.39B | +21.5% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $1.66B | -0.4% |
Compare ACAD, PBH, MDGL, IONS side by side · Screen every company in Pharmaceutical Preparations ↗